Call Options

5 transactions
Quarter Operation Price Per call calls change calls Held SEC Form
Q1 2022

May 11, 2022

SELL
$7.33 - $9.39 $5,864 - $7,512
-800 Reduced 4.42%
17,300 $10,000
Q4 2021

Feb 08, 2022

SELL
$7.9 - $10.19 $1,580 - $2,038
-200 Reduced 1.09%
18,100 $1,000
Q1 2021

May 14, 2021

SELL
$10.34 - $12.81 $5,170 - $6,405
-500 Reduced 2.66%
18,300 $18,000
Q3 2020

Nov 04, 2020

BUY
$8.57 - $12.69 $18,854 - $27,918
2,200 Added 13.25%
18,800 $2,000
Q4 2019

Feb 12, 2020

BUY
$6.53 - $10.72 $108,398 - $177,952
16,600 New
16,600 $10,000

Others Institutions Holding TEVA

About TEVA PHARMACEUTICAL INDUSTRIES LTD


  • Ticker TEVA
  • Exchange OTC
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 1,110,560,000
  • Market Cap $24.5B
  • Description
  • Teva Pharmaceutical Industries Limited, a pharmaceutical company, develops, manufactures, markets, and distributes generic medicines, specialty medicines, and biopharmaceutical products in North America, Europe, and internationally. The company offers sterile products, hormones, high-potency drugs, and cytotoxic substances in various dosage form...
More about TEVA
Track This Portfolio

Track Raymond James Financial Services Advisors, Inc. Portfolio

Follow Raymond James Financial Services Advisors, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Raymond James Financial Services Advisors, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Raymond James Financial Services Advisors, Inc. with notifications on news.